Nifurtimox vs placebo
Clearance or reduction of antibody titres (N) · adults with both late‐stage, symptomatic Chagas disease and CCC
It is very uncertain whether nifurtimox changes clearance or reduction of antibody titres (N) compared with placebo (very low certainty).
1 finding from 1 review
- Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection) 2020 · Cochrane Headline outcomes onlyRR 16.89 [2.44, 116.85]1 study · 51 participantsVery low